Somewhat Negative Press Coverage Somewhat Unlikely to Impact Monsanto (MON) Share Price

News coverage about Monsanto (NYSE:MON) has been trending somewhat negative this week, Accern reports. The research firm rates the sentiment of press coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Monsanto earned a media sentiment score of -0.04 on Accern’s scale. Accern also assigned news articles about the basic materials company an impact score of 42.9906538255253 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

Here are some of the news articles that may have impacted Accern Sentiment’s analysis:

Several research firms recently commented on MON. Barclays reissued an “equal weight” rating and set a $124.00 price target (up from $120.00) on shares of Monsanto in a research report on Thursday, October 5th. BMO Capital Markets reissued a “buy” rating and set a $128.00 price target on shares of Monsanto in a research report on Thursday, October 5th. Macquarie lowered Monsanto from an “outperform” rating to a “neutral” rating in a research report on Wednesday, October 4th. Wells Fargo & Co boosted their price target on Monsanto from $107.50 to $118.00 and gave the stock a “market perform” rating in a research report on Tuesday, October 10th. Finally, Jefferies Group reissued a “hold” rating and set a $128.00 price target on shares of Monsanto in a research report on Friday, September 15th. Eleven investment analysts have rated the stock with a hold rating and two have given a buy rating to the company. Monsanto currently has a consensus rating of “Hold” and a consensus price target of $126.40.

Shares of Monsanto (NYSE:MON) traded up $0.16 on Friday, hitting $119.70. The company’s stock had a trading volume of 2,200,000 shares, compared to its average volume of 3,090,000. Monsanto has a one year low of $106.74 and a one year high of $122.79. The firm has a market cap of $52,690.00, a price-to-earnings ratio of 22.13, a price-to-earnings-growth ratio of 1.69 and a beta of 1.04. The company has a debt-to-equity ratio of 1.05, a quick ratio of 0.79 and a current ratio of 1.28.

Monsanto (NYSE:MON) last announced its earnings results on Thursday, January 4th. The basic materials company reported $0.41 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.42 by ($0.01). Monsanto had a net margin of 16.38% and a return on equity of 40.13%. The business had revenue of $2.66 billion during the quarter, compared to analyst estimates of $2.77 billion. During the same period in the previous year, the company earned $0.21 earnings per share. The business’s revenue for the quarter was up .3% on a year-over-year basis. analysts anticipate that Monsanto will post 5.79 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 26th. Shareholders of record on Friday, January 5th will be given a $0.54 dividend. This represents a $2.16 dividend on an annualized basis and a dividend yield of 1.80%. The ex-dividend date is Thursday, January 4th. Monsanto’s payout ratio is 39.93%.

In other Monsanto news, EVP Steven Mizell sold 8,100 shares of the company’s stock in a transaction that occurred on Tuesday, January 9th. The stock was sold at an average price of $119.35, for a total value of $966,735.00. Following the transaction, the executive vice president now directly owns 56,743 shares of the company’s stock, valued at approximately $6,772,277.05. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CFO Pierre Courduroux sold 4,320 shares of the company’s stock in a transaction that occurred on Thursday, October 19th. The shares were sold at an average price of $122.00, for a total value of $527,040.00. Following the completion of the transaction, the chief financial officer now directly owns 48,388 shares in the company, valued at $5,903,336. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 20,310 shares of company stock worth $2,458,328. 0.70% of the stock is currently owned by corporate insiders.

TRADEMARK VIOLATION WARNING: This piece of content was originally posted by The Ledger Gazette and is owned by of The Ledger Gazette. If you are reading this piece of content on another website, it was copied illegally and republished in violation of international copyright and trademark legislation. The original version of this piece of content can be accessed at https://ledgergazette.com/2018/01/12/somewhat-negative-press-coverage-somewhat-unlikely-to-impact-monsanto-mon-share-price.html.

Monsanto Company Profile

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Insider Buying and Selling by Quarter for Monsanto (NYSE:MON)

Receive News & Ratings for Monsanto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply